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Abstract
The 2018 International Conference on Intelligent Biology and Medicine (ICIBM 2018) was held on June 10–12, 2018,
in Los Angeles, California, USA. The conference consisted of a total of eleven scientific sessions, four tutorials, one
poster session, four keynote talks and four eminent scholar talks, which covered a wild range of aspects of
bioinformatics, medical informatics, systems biology and intelligent computing. Here, we summarize nine research
articles selected for publishing in BMC Bioinformatics.
Introduction
The 2018 International Conference on Intelligent Biology
and Medicine (ICIBM 2016) provided a multidisciplinary
forum for computational scientists and experimental biol-
ogists to share their most recent findings in the field of
cancer genomics, systems biology, medical informatics,
big data analytics and machine learning, among others.
The conference was held on June 10–12, 2018, in Los
Angeles, California, USA. More than 160 researchers and
students across the world attended the meeting. In this
special issue, we have collected nine original research arti-
cles reflecting the cutting edge researches in bioinformat-
ics. As the advance of all kinds of omics studies,
bioinformatics has beome the indispensable powerhouse
behinds all analyses. This is reflected in our selection, as
these papers cover traditional areas in genomics, tran-
scriptomics, proteomics, and literature mining, as well as
new research foci such as Hi-C data and electronic health
record. We also observe a shift of research interest from
developing tools for analyzing high-throughput data to-
wards translational applications. This trend is also evident
in the selection as majority of the studies have a broad
goal of better understanding human diseases. In the fol-
lowing, we briefly summarize the nine selected papers.
The science program for the ICIBM 2018 bioinformatics
track
In the first paper, He et al. [1] developed an innovative
semi-parametric latent variable differential network
model for investigating the structural difference of gen-
etic networks under two experimental conditions, such
as two gene expression data sets. The advantages of this
new model include the capability of handling complex
biological data with various types (discrete or continu-
ous) and relaxing normality assumption that often does
not hold in the real data. Theoretical analysis demon-
strated that the new methods achieve the same paramet-
ric convergence rate for both the differential structure
recovery and difference of the precision matrices estima-
tion. Numerical simulation and real application also
showed the advantages of the new model as to providing
deeper understanding of the mechanism of diseases.
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Top-down mass spectrometry performs particularly
well in identifying proteoforms with multiple modifica-
tions and/or alterations. When applying this technology
to a species that does not have a reference protein se-
quence database for proteoform identification, a hom-
ologous protein sequence databased can be used as an
alternative. Li et al. [2] evaluated the performance of
TopPIC, a commonly used software for top-down mass
spectral identification, on top-down mass spectral identi-
fication with homologous protein sequences. A Escheri-
chia coli K12 MG1655 and a human MCF-7 cells
top-down mass spectrometry data sets were used in the
evaluation. For each data set, the mass spectra were
searched separately against a reference proteome data-
base and a homologous proteome database. The results
showed that TopPIC is able to identify many proteoform
spectrum matches and localize unknown alterations
using homologous protein sequences with no more than
2 mutations.
In the third paper, Shen [3] reported DLAD4U (Disease
List Automatically Derived For You), a new web-based
disease retrieval and prioritization tool based on PubMed
literature. It utilizes existing resources of the NCBI to
achieve computational efficiency and statistical analyses to
ensure accuracy. Easy usage and interpretation of the re-
sults is achieved via a simple Google-like interface. Using
selected genes and drugs as query terms and manually cu-
rated data as “gold standard”, the authors demonstrated
the superior performance of DLAD4U compared to other
disease search engines.
In the next paper, Liu and Wang [4] addressed one of the
key issues of using Hi-C data: the unclear relationship be-
tween spatial distance and the number of Hi-C contacts. This
relationship is essential for understanding some significant
biological functions, such as the enhancer-promoter interac-
tions. The authors proposed a new method for inferring the
converting parameter and the pairwise Euclidean distances
based on the topology of Hi-C complex network (HiCNet).
The inferred distances had a higher correlation with fluores-
cence in situ hybridization (FISH) data, fitted the localization
patterns of Xist transcripts on DNA, and better matched 156
pairs of protein-enabled long-range chromatin interactions
detected by ChIA-PET. A 40 kb high-resolution 3D chromo-
somal structures of mouse male ES cells were then recon-
structed using the new method.
One of the consistent challenges in precision medicine
is to accurately predict the sensitivity of a tumor to an
anti-cancer compound. Large-scale pharmacogenomics
studies, like CCLE and GDSC, hold the promise for
designing an accurate prediction model. However, inte-
grating information from multiple resources faces the
challenge of removing the distribution shift between
data. Dhruba et al. [5] proposed to use transfer learning
methodologies to eliminate this distribution shift and
design effective drug sensitivity prediction models in a tar-
get database by incorporating data from a secondary data-
base. More specifically, the authors presented two novel
approaches based on latent variable cost optimization and
polynomial mapping. With different scenarios, they dem-
onstrated that the proposed approaches accomplish a bet-
ter prediction of drug sensitivities compared to database-
specific individual models and existing transfer learning
approaches, with the nonlinear mapping model exhibits
the best overall performance.
Identifying local recurrences in breast cancer patients
is important for clinical research and practice. Zeng et
al. [6] proposed a novel concept-based filter and a pre-
diction model to detect local recurrences using elec-
tronic health records (EHR) of breast cancer patients.
Unlike typical clinical NLP (natural language processing)
systems, the authors proposed to utilize a positive set of
concepts related to breast cancer local recurrence using
MetaMap, a tool for identifying medical concepts in text.
The new model was compared with three baseline classi-
fiers using either full MetaMap concepts, filtered Meta-
Map concepts, or bag of words. The results showed that
the new model achieved the best performance and pro-
vided an automated and effective way to identify breast
cancer local recurrences.
Chowdhury et al. [7] proposed another new method for
analyzing electronic medical record (EMR). The new
method is targeting a challenge in Entity Recognition
(NER), a sub-field of information extraction aimed at iden-
tifying specific entity terms such as disease, test, symptom,
genes etc., in the situation when the available EMR is lim-
ited. The authors proposed a multitask bi-directional RNN
model as a potential solution of data augmentation to en-
hance NER performance with limited data. The evaluation
test showed the superior performance of the proposed
model compared to the baseline model in terms of micro
average F-score, macro average F-score and accuracy.
Studying disease-disease relationships has wide applica-
tions in biomedical field, such as understanding disease
mechanism and drug discovery. The FDA Adverse Event
Reporting System (FAERS) contains rich information
about patient diseases, medications, drug adverse events
etc. Zheng and Xu [8] systematically explored this data re-
source to construct a disease comorbidity network (DCN)
with 1,059 disease nodes and 12,608 edges using associ-
ation rule mining (14,157 rules). The DCN shows good
performance in capturing known disease comorbidities
and is well correlated with disease semantic similarity, dis-
ease genetics and disease treatment. Using asthma as a
case study, the authors also demonstrated that the DCN
has potential in uncovering novel disease relationships.
In the last paper, Khan et al. [9] developed a computational
tool, integrated Mental-disorder GEnome Score (iMEGES),
to prioritize disease-relevant genes and variants with personal
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genomes. The new tool uses deep neural network ap-
proaches to integrate diverse sources of input information,
including whole-genome variants and clinical phenotype
terms of an individual with mental disorders, and outputs
prioritized lists of variants and genes that may be relevant to
the phenotypes. iMEGES was evaluated using multiple data-
sets of mental disorders, and achieved improved perform-
ance compared to competing approaches. The tool can be
used in population studies for prioritizing novel genes or
variants associated with disease susceptibility, as well as on
individual patients for identifying genes or variants with large
effect on mental disorders.
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